Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules
- PMID: 2014234
- PMCID: PMC51403
- DOI: 10.1073/pnas.88.8.3150
Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules
Abstract
HLA-DR molecules are heterodimeric transmembrane glycoproteins that associate intracellularly with a polypeptide known as the invariant (I) chain. Shortly before expression of the HLA-DR alpha beta dimer on the cell surface, however, the I chain is removed from the intracellular alpha beta I complex by a mechanism thought to involve proteolysis. In this report, we show that treatment of purified alpha beta I with the cysteine proteinase cathepsin B results in the specific proteolysis of the HLA-DR-associated I chain in vitro. As a consequence of this, the I chain is removed and free alpha beta dimers are released from alpha beta I. Although alpha beta I fails to bind an immunogenic peptide, the released alpha beta dimers acquire the ability to bind the peptide after proteolysis of the I chain. These results suggest that the I chain inhibits immunogenic peptide binding to alpha beta I early during intracellular transport and demonstrate that proteolysis is likely to be the in vivo mechanism of I chain removal.
Similar articles
-
Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA. 1991. 88: 3150-3154.J Immunol. 2011 Aug 1;187(3):1076-80. J Immunol. 2011. PMID: 21772034
-
Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.Nature. 1990 Jun 14;345(6276):615-8. doi: 10.1038/345615a0. Nature. 1990. PMID: 2190094
-
Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.J Immunol. 1995 Jan 1;154(1):137-50. J Immunol. 1995. PMID: 7995933
-
Interactions between immunogenic peptides and HLA-DR molecules.Immunol Res. 1990;9(3):178-89. doi: 10.1007/BF02918177. Immunol Res. 1990. PMID: 2230404 Review. No abstract available.
-
Intracellular transport and peptide binding properties of HLA class II glycoproteins.Semin Immunol. 1990 Jul;2(4):273-80. Semin Immunol. 1990. PMID: 2104276 Review.
Cited by
-
The endo/lysosomal protease cathepsin B is able to process conalbumin fragments for presentation to T cells.Immunology. 1991 Nov;74(3):393-8. Immunology. 1991. PMID: 1769688 Free PMC article.
-
Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells.J Cell Biol. 2001 Oct 1;155(1):53-63. doi: 10.1083/jcb.200103071. J Cell Biol. 2001. PMID: 11581285 Free PMC article.
-
Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells.J Cell Biol. 1999 Nov 15;147(4):775-90. doi: 10.1083/jcb.147.4.775. J Cell Biol. 1999. PMID: 10562280 Free PMC article.
-
HLA Class II Histocompatibility Antigen γ Chain (CD74) Expression Is Associated with Immune Cell Infiltration and Favorable Outcome in Breast Cancer.Cancers (Basel). 2021 Dec 8;13(24):6179. doi: 10.3390/cancers13246179. Cancers (Basel). 2021. PMID: 34944801 Free PMC article.
-
Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways.J Exp Med. 1993 Jul 1;178(1):73-85. doi: 10.1084/jem.178.1.73. J Exp Med. 1993. PMID: 8315396 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
